Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Immatics Biotech begins phase III IMA-901 trial in renal cell carcinoma

Dec. 31, 2010

Medimmune begins phase Ib/II trial of MEDI-575 in NSCLC

Dec. 31, 2010

BioCancell Therapeutics completes preclinical studies of BC-821 for glioblastoma

Dec. 31, 2010

HER2-Affitoxin is a potential therapeutic for HER2-overexpressing tumors

Dec. 31, 2010

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Bristol-Myers Squibb and Otsuka to copromote Sprycel in Japan

Dec. 30, 2010

Phase I/II trial of belinostat/Tarceva combination in NSCLC advances

Dec. 30, 2010

Ziopharm Oncology treats first patient in phase I trial of palifosfamide

Dec. 30, 2010

New inhibitors of focal adhesion kinase 1 claimed

Dec. 30, 2010

MK-0752 shows promise in patients with breast cancer

Dec. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...